GO:0006864 pyrimidine nucleotide transport: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006864 pyrimidine nucleotide transport describes the directed movement of pyrimidine nucleotides (e.g., CTP, UTP, UDP-sugars) across cellular membranes or within compartments.
• This process is essential for supplying nucleotide sugars for glycosylation, nucleic acid synthesis, and phospholipid metabolism.
• Key transporters include SLC28 family members (concentrative nucleoside transporters) and mitochondrial carriers such as SLC25A33, which regulate pyrimidine nucleotide pools.
• Dysregulation of pyrimidine nucleotide transport is linked to cancer metabolism, ferroptosis, and mitochondrial dysfunction.
• CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of transport proteins in disease.
• Studying this process requires integrated approaches: transport assays, metabolomics, and imaging of nucleotide pools.
Description
Pyrimidine nucleotide transport (GO:0006864) is a fundamental biological process that ensures the proper distribution of pyrimidine nucleotides such as CTP, UTP, and UDP-sugars across cellular membranes and between subcellular compartments. These molecules are not only building blocks of RNA and DNA but also key donors in glycosylation and phospholipid synthesis. The directed movement of these charged metabolites is mediated by specialized transporter proteins, as nucleotides cannot freely diffuse across lipid bilayers. Understanding this process is critical for researchers in cancer metabolism, mitochondrial biology, and glycobiology, because altered transport can reprogram cellular metabolism and contribute to disease.
pyrimidine nucleotide transport At A Glance
| GO ID | GO:0006864 |
|---|---|
| GO term | pyrimidine nucleotide transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of pyrimidine nucleotides across membranes or within cells |
| Major transporters | SLC28 family, SLC25A33, UDP-galactose transporter |
| Associated diseases | Cancer, mitochondrial disorders, ferroptosis |
| Research methods | CRISPR screens, metabolomics, transport assays, imaging |
What Is GO:0006864?
According to the Gene Ontology, pyrimidine nucleotide transport (GO:0006864) is the directed movement of a pyrimidine nucleotide, any compound consisting of a pyrimidine nucleoside esterified with (ortho)phosphate, into, out of or within a cell. This includes the translocation of molecules like CTP, UTP, and UDP-glucose across biological membranes, a process that requires specific transporter proteins.
Why Is pyrimidine nucleotide transport Important in Cell Biology?
Pyrimidine nucleotide transport is essential for maintaining cellular nucleotide homeostasis, which directly impacts nucleic acid synthesis, protein glycosylation, and membrane lipid metabolism. Defects in transport proteins can lead to imbalanced nucleotide pools, mitochondrial dysfunction, and altered metabolic flux, contributing to cancer progression and other diseases. Therefore, studying this process provides insights into fundamental cell biology and identifies potential therapeutic targets.
• Supplies nucleotide sugars for glycosylation and glycoprotein synthesis.
• Regulates mitochondrial pyrimidine nucleotide pools, affecting energy metabolism.
• Modulates ferroptosis sensitivity via DHODH and pyrimidine metabolism.
• Impacts phospholipid metabolism through CTP-dependent pathways.
• Influences nucleoside analog drug efficacy by controlling intracellular drug transport.
• Plays a role in plant development and stress responses.
• Dysregulation is linked to cancer metabolic reprogramming (Warburg effect).
• Provides targets for CRISPR-based functional genomics.
• Essential for RNA and DNA precursor supply in proliferating cells.
• Contributes to intercellular signaling via nucleotide release.
What Happens During pyrimidine nucleotide transport?
Substrate recognition and binding
In simple terms: Transporters must first grab the pyrimidine nucleotide they will carry.
Transport proteins such as SLC28 family members and mitochondrial carriers recognize pyrimidine nucleotides with high specificity, binding them at the membrane interface. Structural studies of related nucleotide sugar transporters reveal conserved binding pockets that accommodate the pyrimidine ring and phosphate groups.
Translocation across the membrane
In simple terms: The transporter then flips the nucleotide from one side of the membrane to the other.
Once bound, the transporter undergoes conformational changes to move the pyrimidine nucleotide across the lipid bilayer, either down its concentration gradient (facilitated diffusion) or against it (active transport). For example, the UDP-galactose transporter mediates the entry of UDP-galactose into the Golgi lumen for glycosylation.
Release and metabolic channeling
In simple terms: After crossing, the nucleotide is released to be used by enzymes.
Inside the target compartment, the transported pyrimidine nucleotide is released and rapidly utilized by metabolic enzymes, such as glycosyltransferases in the Golgi or DNA/RNA polymerases in the nucleus. This channeling ensures efficient substrate supply and prevents toxic accumulation.
Regulation of transport activity
In simple terms: Cells adjust transport rates based on need.
Transport activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and feedback inhibition by downstream metabolites. Mitochondrial pyrimidine nucleotide transport is coupled to glucose metabolism, highlighting metabolic integration.
Key Genes Involved in GO:0006864 pyrimidine nucleotide transport
The following genes encode proteins directly involved in pyrimidine nucleotide transport or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC28A1 | Concentrative nucleoside transporter; mediates pyrimidine nucleoside uptake | Drug transport, cancer chemotherapy |
| SLC28A2 | Sodium-coupled nucleoside transporter | Nucleoside analog sensitivity |
| SLC28A3 | Broadly selective nucleoside transporter | Pyrimidine nucleoside transport |
| SLC25A33 | Mitochondrial pyrimidine nucleotide transporter | Mitochondrial metabolism, glucose transport regulation |
| SLC25A36 | Mitochondrial pyrimidine nucleotide carrier | Mitochondrial nucleotide homeostasis |
| SLC35A1 | UDP-galactose transporter | Glycosylation, Golgi transport |
| SLC35A2 | UDP-galactose transporter | Congenital disorders of glycosylation |
| SLC35A3 | UDP-N-acetylglucosamine transporter | Glycosylation |
| SLC35B1 | UDP-xylose transporter | Proteoglycan synthesis |
| SLC35C1 | GDP-fucose transporter | Not directly pyrimidine but related nucleotide sugar transport |
| DHODH | Dihydroorotate dehydrogenase; pyrimidine synthesis | Ferroptosis, cancer metabolism |
| UMPS | Uridine monophosphate synthase | Pyrimidine synthesis |
| CTPS1 | CTP synthase 1 | Pyrimidine nucleotide synthesis |
| CTPS2 | CTP synthase 2 | Pyrimidine nucleotide synthesis |
| NME1 | Nucleoside diphosphate kinase | Nucleotide metabolism |
| ENT1 (SLC29A1) | Equilibrative nucleoside transporter | Nucleoside transport |
| ENT2 (SLC29A2) | Equilibrative nucleoside transporter | Nucleoside transport |
| CNT3 (SLC28A3) | Concentrative nucleoside transporter | Pyrimidine nucleoside transport |
How Is pyrimidine nucleotide transport Regulated?
Pyrimidine nucleotide transport is regulated by metabolic demand, hormonal signals, and cellular stress. For instance, mitochondrial pyrimidine nucleotide transport is modulated by glucose availability, linking transport to energy status. Additionally, the expression of nucleoside transporters can be induced by cytokines and growth factors, affecting drug uptake. At the post-translational level, phosphorylation and ubiquitination of transporters control their surface localization and activity.
pyrimidine nucleotide transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A33 | Mitochondrial dysfunction, glucose intolerance | Knockout in C. elegans or mammalian cells |
| DHODH | Ferroptosis, cancer | Knockout or point mutation in cancer cell lines |
| SLC28A1 | Drug resistance in cancer | Overexpression in HeLa cells |
| SLC35A1 | Congenital disorder of glycosylation | Knock-in of patient mutations in HEK293 |
| CTPS1 | Immunodeficiency | Knockout in T cells |
Cancer metabolism and ferroptosis
Altered pyrimidine nucleotide transport supports the high biosynthetic demands of cancer cells. The Warburg effect modulates DHODH, a key enzyme in pyrimidine synthesis, influencing ferroptosis sensitivity. Transporters like SLC28A1 affect the uptake of chemotherapeutic nucleoside analogs, impacting drug resistance.
Mitochondrial dysfunction
Mutations in mitochondrial pyrimidine nucleotide transporters such as SLC25A33 can impair mitochondrial function and glucose homeostasis, as shown in C. elegans models. This links transport defects to metabolic disorders.
Congenital disorders of glycosylation
Defects in UDP-galactose transport (SLC35A1) cause glycosylation disorders, highlighting the importance of pyrimidine nucleotide sugar transport in human disease.
From pyrimidine nucleotide transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC25A33 regulate glucose transport? | Knockout in C. elegans |
| How does DHODH modulate ferroptosis? | Point mutation (e.g., active site) in cancer cells |
| What is the role of UDP-galactose transport in glycosylation? | Knock-in of tagged SLC35A1 in HEK293 |
| Can overexpression of SLC28A1 increase drug uptake? | Overexpression in HeLa cells |
| Does loss of CTPS1 affect nucleotide pools? | Knockout in Jurkat cells |
| How is pyrimidine transport regulated by glucose? | Knockout + rescue in mammalian cells |
How to Study the pyrimidine nucleotide transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and kinetics | Characterize SLC28A1 function |
| LC-MS metabolomics | Intracellular nucleotide levels | Assess DHODH inhibition |
| CRISPR knockout screen | Gene essentiality for transport | Identify novel transporters |
| Fluorescence microscopy | Subcellular localization | Track tagged SLC35A1 |
| RNA-seq | Transcriptional changes | Measure transporter expression |
| Proteomics | Protein interactions | Find transport complexes |
| Transport reconstitution | Direct transport activity | Study purified SLC25A33 |
| Genetic complementation | Functional rescue | Validate patient mutations |
Transport assays
Radiolabeled or fluorescent pyrimidine nucleotides can be used to measure uptake in cells or isolated organelles, providing direct kinetic data.
Metabolomics and nucleotide profiling
LC-MS-based metabolomics quantifies intracellular nucleotide pools, revealing changes upon transporter knockout or overexpression.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes required for pyrimidine nucleotide transport and sensitivity to nucleoside analogs.
Imaging and subcellular localization
Fluorescently tagged transporters and nucleotide sensors enable live-cell imaging of transport dynamics and compartmentalization.
How CRISPR Can Be Used to Study GO:0006864 pyrimidine nucleotide transport
Knockout
CRISPR knockout of pyrimidine nucleotide transporters (e.g., SLC25A33) can reveal their essential roles in metabolism and glucose homeostasis. Knockout of DHODH sensitizes cells to ferroptosis inducers.
Point Mutation
Introducing point mutations in transporter active sites (e.g., SLC35A1) can dissect substrate specificity and catalytic residues. Point mutations in DHODH can modulate its enzymatic activity and ferroptosis response.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC28A1) allows real-time imaging and localization studies. Knock-in of patient mutations in SLC35A1 models congenital glycosylation disorders.
Overexpression
Overexpression of SLC28A1 or SLC25A33 can enhance transport capacity and alter drug sensitivity, providing gain-of-function models.
How EDITGENE Supports pyrimidine nucleotide transport Research
Researchers studying pyrimidine nucleotide transport-related genes often need to determine whether a candidate gene is causally involved in metabolite flux, disease phenotypes, or drug response. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for pyrimidine nucleotide transport research.
Frequently Asked Questions About pyrimidine nucleotide transport
What is pyrimidine nucleotide transport?
Pyrimidine nucleotide transport (GO:0006864) is the directed movement of pyrimidine nucleotides such as CTP and UTP across cellular membranes or within cells, mediated by specific transporter proteins.
What genes are involved in pyrimidine nucleotide transport?
Key genes include SLC28A1, SLC28A2, SLC28A3, SLC25A33, SLC25A36, SLC35A1, and DHODH, among others.
How is pyrimidine nucleotide transport regulated?
It is regulated by metabolic demand, glucose availability, transcriptional control, and post-translational modifications of transporters.
Why is pyrimidine nucleotide transport important in cancer?
It supports the high biosynthetic needs of cancer cells and influences sensitivity to ferroptosis and chemotherapy.
What diseases are linked to defects in pyrimidine nucleotide transport?
Mitochondrial dysfunction, congenital disorders of glycosylation, and cancer metabolic reprogramming.
What methods are used to study pyrimidine nucleotide transport?
Transport assays, metabolomics, CRISPR screens, and imaging are commonly used.
Can CRISPR be used to study pyrimidine nucleotide transport?
Yes, CRISPR knockout, knock-in, and overexpression models enable functional dissection of transporter genes.
What is the role of SLC25A33 in pyrimidine nucleotide transport?
SLC25A33 is a mitochondrial pyrimidine nucleotide transporter that regulates glucose transport and mitochondrial metabolism.
How does DHODH relate to pyrimidine nucleotide transport?
DHODH is a key enzyme in pyrimidine synthesis, and its activity is linked to ferroptosis and cancer metabolism.
What are the synonyms for GO:0006864?
The Gene Ontology lists no synonyms for pyrimidine nucleotide transport.
Conclusion
Pyrimidine nucleotide transport (GO:0006864) is a critical process that ensures the proper distribution of nucleotides for nucleic acid synthesis, glycosylation, and energy metabolism. Dysregulation of this process is implicated in cancer, mitochondrial disorders, and glycosylation defects. Leveraging CRISPR-based models and multi-omics approaches will continue to uncover new therapeutic opportunities targeting pyrimidine nucleotide transport.
References
- 1. Ahuja S et al.. 2019. Structural basis for mammalian nucleotide sugar transport.. Elife 8 PMID: 30985278
- 2. Ogurusu T et al.. 2021. The Caenorhabditis elegans homolog of human mitochondrial pyrimidine nucleotide transporter regulates glucose transport.. Biochem Biophys Res Commun 557:117-121 PMID: 33862454
- 3. Ishida N et al.. 1997. [UDP galactose transporter].. Seikagaku 69(9):1101-6 PMID: 9364878
- 4. Möhlmann T et al.. 2010. Nucleoside transport and associated metabolism.. Plant Biol (Stuttg) 12 Suppl 1:26-34 PMID: 20712618
- 5. van den Bosch H. 1974. Phosphoglyceride metabolism.. Annu Rev Biochem 43(0):243-77 PMID: 4604904
- 6. Lazarowski ER et al.. 2011. Molecular mechanisms of purine and pyrimidine nucleotide release.. Adv Pharmacol 61:221-61 PMID: 21586361
- 7. Gray JH et al.. 2004. The concentrative nucleoside transporter family, SLC28.. Pflugers Arch 447(5):728-34 PMID: 12856181
- 8. Amos A et al.. 2023. The Warburg effect modulates DHODH role in ferroptosis: a review.. Cell Commun Signal 21(1):100 PMID: 37147673
